Post-IPO Equity Health Care Companies

Rocket Doctor AI offers AI-powered healthcare software and services that support virtual patient care across the full clinical journey.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

HWH International provides services in various lifestyle industries such as healthcare, wealth planning, leisure, travel, and more.

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

Xlife Sciences focuses on the performance and growth of life science technologies.

CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.